Nov 09, 2023 / 12:30PM GMT
Operator
Ladies and gentlemen, good day and welcome to the Suven Pharmaceuticals Limited Q2 and H1 FY24 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
Before we begin, I would like to mention that some statements made in today's discussion may be forward-looking in nature and may involve risks and uncertainties. Documents relating to the company's performance have been emailed to you earlier.
I now hand the conference over to Head IR, Ms. Cyndrella Carvalho, Suven Pharmaceuticals Limited.
Cyndrella Carvalho - Suven Pharmaceuticals Limited - IR
Thanks, Pavan. Good evening, everyone. Today, we have our management team with us. I'll introduce you to our management team members. Mr. Annaswamy Vaidheesh, Executive Chairman; Dr. V. Prasada Raju, Managing Director; and Dr. Sudhir Kumar Singh, Chief Executive Officer; Mr. Venkatraman Sunder, VP, Corporate Affairs; and Mr. P. Subba Rao, Chief Financial Officer.
I will now turn over the call to Vaidheesh for the opening remarks.
Q2 2024 Suven Pharmaceuticals Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot